Tangeretin

Tangeretin is a lipid of Polyketides (PK) class. Tangeretin is associated with abnormalities such as Cardiovascular Diseases, Complex Regional Pain Syndromes, Blood Clot, Hypercholesterolemia and Restenosis. The involved functions are known as Thrombus, Platelet function, Localized desquamation, Platelet Activation and Signal. Tangeretin often locates in Protoplasm, Cytoplasmic Granules, Cytoplasmic matrix, Plasma membrane and Blood. The associated genes with Tangeretin are GP6 gene, CDK2 gene, CDK6 gene, Tumor Suppressor Genes and CDH1 gene. The related lipids are Lipopolysaccharides. The related experimental models are Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Tangeretin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tangeretin?

Tangeretin is suspected in Complex Regional Pain Syndromes, Cardiovascular Diseases, Blood Clot, Hypercholesterolemia, Restenosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tangeretin

MeSH term MeSH ID Detail
Diabetes Mellitus D003920 90 associated lipids
Lung Neoplasms D008175 171 associated lipids
Reperfusion Injury D015427 65 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Parkinson Disease D010300 53 associated lipids
Per page 10 20 | Total 13

PubChem Associated disorders and diseases

What pathways are associated with Tangeretin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tangeretin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tangeretin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tangeretin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Tangeretin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tangeretin?

Mouse Model

Mouse Model are used in the study 'Methoxyflavones protect cells against endoplasmic reticulum stress and neurotoxin.' (Takano K et al., 2007) and Mouse Model are used in the study 'Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer.' (Bracke ME et al., 1999).

Transgenic Model

Transgenic Model are used in the study 'Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?' (Walle T, 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tangeretin

Download all related citations
Per page 10 20 50 100 | Total 222
Authors Title Published Journal PubMed Link
pmid:
Wang MS et al. Inhibition of 11beta-hydroxysteroid dehydrogenase in guinea pig kidney by three bioflavonoids and their interactions with gossypol. 2002 Acta Pharmacol. Sin. pmid:11860745
Guo XQ et al. Tangeretin alters neuronal apoptosis and ameliorates the severity of seizures in experimental epilepsy-induced rats by modulating apoptotic protein expressions, regulating matrix metalloproteinases, and activating the PI3K/Akt cell survival pathway. 2017 Adv Med Sci pmid:28501723
Brack ME et al. The citrus methoxyflavone tangeretin affects human cell-cell interactions. 2002 Adv. Exp. Med. Biol. pmid:12083457
Takano K et al. Methoxyflavones protect cells against endoplasmic reticulum stress and neurotoxin. 2007 Am. J. Physiol., Cell Physiol. pmid:16971492
Yi LZ et al. Quality control and discrimination of pericarpium citri reticulatae and pericarpium citri reticulatae viride based on high-performance liquid chromatographic fingerprints and multivariate statistical analysis. 2007 Anal. Chim. Acta pmid:17386812
Yi LZ et al. Fingerprinting alterations of secondary metabolites of tangerine peels during growth by HPLC-DAD and chemometric methods. 2009 Anal. Chim. Acta pmid:19664461
Tistaert C et al. Quality control of Citri reticulatae pericarpium: exploratory analysis and discrimination. 2011 Anal. Chim. Acta pmid:21962354
Rooprai HK et al. Influence of putative antiinvasive agents on matrix metalloproteinase secretion by human neoplastic glia in vitro. 1999 Ann. N. Y. Acad. Sci. pmid:10415799
Bracke ME et al. Plant polyphenolics as anti-invasive cancer agents. 2008 Anticancer Agents Med Chem pmid:18288920
Kandaswami C et al. Differential inhibition of proliferation of human squamous cell carcinoma, gliosarcoma and embryonic fibroblast-like lung cells in culture by plant flavonoids. 1992 Anticancer Drugs pmid:1450447
Vaiyapuri S et al. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:24135020
Meiyanto E et al. Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. 2012 Asian Pac. J. Cancer Prev. pmid:22524801
Whitman SC et al. Nobiletin, a citrus flavonoid isolated from tangerines, selectively inhibits class A scavenger receptor-mediated metabolism of acetylated LDL by mouse macrophages. 2005 Atherosclerosis pmid:15585197
Nagase H et al. Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities. 2005 Biochem. Biophys. Res. Commun. pmid:16253614
Quintieri L et al. Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. 2008 Biochem. Pharmacol. pmid:18191104
Chen KH et al. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. 2007 Biochem. Pharmacol. pmid:17067555
Lakshmi A and Subramanian S Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats. 2014 Biochimie pmid:24299963
Eguchi A et al. Suppressive effects of demethylated metabolites of nobiletin on phorbol ester-induced expression of scavenger receptor genes in THP-1 human monocytic cells. 2007 Biofactors pmid:18806314
Siess MH et al. Mechanisms involved in the chemoprevention of flavonoids. 2000 Biofactors pmid:11216486